How do cancer cells differ in their mitotic process?

Cancer cells differ in their mitotic process as they divide uncontrollably and do not undergo normal cell cycle regulation.

In a healthy cell, the process of mitosis is tightly regulated by the cell cycle, a series of events that ensure the cell divides correctly. This includes a phase where the cell checks for any DNA damage before it proceeds to divide. If any damage is detected, the cell will either repair the damage or, if it's too severe, trigger cell death to prevent the damaged cell from dividing and potentially causing harm.

However, in cancer cells, this regulation is disrupted. These cells have mutations in their DNA that affect the genes responsible for controlling the cell cycle. This means that cancer cells can divide even when they have DNA damage, or when they are not attached to other cells, which is normally a requirement for cell division. This uncontrolled division leads to the formation of a tumour, a mass of cancer cells.

Furthermore, cancer cells can also undergo changes that allow them to evade the immune system, which would normally recognise and destroy abnormal cells. They can also stimulate the formation of new blood vessels to supply the tumour with nutrients, a process known as angiogenesis.

In addition, cancer cells often have an abnormal number of chromosomes, a condition known as aneuploidy. This is because the normal process of chromosome segregation during mitosis can be disrupted in cancer cells, leading to the incorrect distribution of chromosomes to the daughter cells. This can contribute to the genetic instability of cancer cells, allowing them to acquire new mutations and become more aggressive.

In summary, the mitotic process in cancer cells is characterised by uncontrolled division, evasion of the immune system, stimulation of angiogenesis, and often aneuploidy. These differences allow cancer cells to grow and spread in the body, leading to the development of cancer.